Department of Digestive Surgery and Transplantation, Univ Lille Nord de France, CHU Lille, France.
Aliment Pharmacol Ther. 2010 Aug;32(3):459-65. doi: 10.1111/j.1365-2036.2010.04369.x. Epub 2010 May 22.
Ileocaecal resection for penetrating Crohn's disease is still challenging with a high rate of post-operative morbidity and faecal diversion.
To report retrospectively the results of pre-operative management for penetrating Crohn's disease focusing on the rate of post-operative major morbidities and need for faecal diversion.
Between 1997 and 2007, 78 patients with penetrating Crohn's disease underwent a first ileocaecal resection after a pre-operative management consisting in bowel rest, nutritional therapy, intravenous antibiotics, weaning off steroids and immunosuppressors, and drainage of abscesses when appropriate.
Resection was performed for terminal ileitis associated with (n = 41), abscesses (n = 37) or both (n = 5). A pre-operative nutritional therapy was performed in 50 patients (68%) for 23 days (range, 7-69 days) along with a weaning off steroids and immunosuppressors. A diverting stoma was performed for six patients (7.7%). There was no post-operative death. Post-operative complications were classified as minor in 10 patients (12.8%), and major in four patients (5%). Overall, the post-operative course was uneventful in 58 patients (74%).
Pre-operative management for penetrating Crohn's disease allowed ileocaecal resection with low rates of post-operative morbidity and faecal diversion.
穿透性克罗恩病的回肠结肠切除术仍然具有挑战性,术后发病率高,需要粪便转流。
回顾性报告穿透性克罗恩病的术前管理结果,重点关注术后主要并发症的发生率和粪便转流的需求。
1997 年至 2007 年间,78 例穿透性克罗恩病患者在术前管理后接受了第一次回肠结肠切除术,术前管理包括肠道休息、营养治疗、静脉抗生素、逐渐减少类固醇和免疫抑制剂的使用以及脓肿引流(如果适当)。
手术切除的病变部位为末端回肠炎(n=41)、脓肿(n=37)或两者兼有(n=5)。50 例患者(68%)接受了术前营养治疗,治疗时间为 23 天(范围为 7-69 天),同时逐渐减少了类固醇和免疫抑制剂的使用。6 例患者(7.7%)行预防性肠造口术。无术后死亡病例。术后并发症分为轻度 10 例(12.8%)和重度 4 例(5%)。总体而言,58 例患者(74%)术后恢复顺利。
穿透性克罗恩病的术前管理可使患者接受回肠结肠切除术,术后发病率和粪便转流率较低。